OpenAlex
PricingAboutJobs
Log inGet started
Work

Phase II trial of doxil for patients with metastatic melanoma refractory to frontline therapy.

HTML

Year: 1999
Type: article
Study design: Clinical Trial
Source: Oncology Reports
DOI: 10.3892/or.6.5.1097
Authors: J A Ellerhorst, A Bedikian, S Ring, A C Buzaid, O Eton, S S Legha
Institution: The University of Texas MD Anderson Cancer Center
Language: English

Topic: Cutaneous Melanoma Detection and Management
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: pegylated liposomal doxorubicin, metastatic melanoma, stage IV melanoma, refractory melanoma, second-line therapy, hand-foot syndrome, stomatitis, rash, anticancer activity, dose reduction
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2058578539
FWCI: 1.637
Cites:
Cited by: 54
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security